Saturday, January 26, 2019 10:20:39 AM
Two things...
First... Just as an FYI, my name is Sterling and not Steve. People have a tendency to see my codename of stervc and see it as Steve.
Second... This is the beauty about VYST. I think investors are only thinking that acquiring Rotmans which generates over $35 Million in Revenues is the only thing that is going to be in existence here with VYST. It's not. It was mentioned that they believe they are going to be creating a company that will be a $1 billion company. Vytex and its technology will be instrumental in graduating VYST to those levels. I think all should read what you have posted below:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146149976
steve and cj: Thanks for your work.
I have sold almost every other holding and have comfortably parked it here. I have used Rotman's for furniture, and they are truly a class act. But, this is not just a furniture play.
My company is involved in medical devices. Our device goes into the ER, ambulances and rooms where patients have contagious diseases.
This company could reshape the manufacturing of plastics for the benefit of healthcare workers and the patients. If the next NEWS is about VYTEX, we will never look back.
Latex allergies and powdered gloves have become a major concern in the healthcare industry, with some facilities banning latex gloves and the US recently banning powdered gloves. However, surgeons and medical professionals prefer latex over synthetic latex, vinyl and other materials due to its superior tactile sensitivity, puncture resistance, strength, durability and flexibility.
This presents a tremendous market opportunity for Vytex medical gloves as they are virtually free of allergy-causing proteins while providing all the benefits of latex that healthcare workers want, and they don’t need powder to ease glove donning and removal.
v/r
Sterling
Exit Strategy & Etiquette Thoughts for a Stock
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128822531
I never give investing advice; only my beliefs for risks in a stock.
Recent VYST News
- Vystar and R3alm Launch R3alm.com Following Strategic Transaction • GlobeNewswire Inc. • 04/21/2026 12:00:00 PM
- Vystar Enters into Binding Letter of Intent to Acquire 50% Interest in R3alm Inc. • GlobeNewswire Inc. • 04/20/2026 01:22:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2026 06:25:19 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/30/2026 03:33:28 PM
- Vystar Announces 2-Week-Long Memorabilia Sweepstakes on X Platform • GlobeNewswire Inc. • 02/18/2026 02:30:00 PM
- Vystar Enters Final Testing of Breakthrough Dialysis Water Filtration Technology • GlobeNewswire Inc. • 01/29/2026 03:40:00 PM
- Vystar to Acquire Stake in GoPaid and Partner with Capital R3alm to Launch R3alm Oracle and Collectibles Platform • GlobeNewswire Inc. • 01/27/2026 03:57:10 PM
- Vystar Corp. Submits Binding Letter of Intent to Acquire Stake in GoPaid.com LLC and Form Strategic Partnership with Capital R3alm to Launch R3alm Oracle and R3alm Collectibles • GlobeNewswire Inc. • 01/08/2026 04:40:38 PM
- Vystar® Reports, Following its First of its Kind Court Victory against EMA Financial, Inc. of $497,439.58 in Legal Fees and Costs Awarded. • GlobeNewswire Inc. • 12/22/2025 08:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 05:59:16 PM
- Incubator Stock Review Initiates Coverage on Vystar • GlobeNewswire Inc. • 10/24/2025 02:05:00 PM
- Vystar’s Vytex® Cloud Bed-in-a-Box Available for Sale • GlobeNewswire Inc. • 10/17/2025 12:30:00 PM
- Vystar® to restart sales of Vytex® Cloud Bed-in-a-Box • GlobeNewswire Inc. • 09/12/2025 01:20:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2025 04:16:02 PM
